Literature DB >> 7999426

A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes.

P R Twentyman1, T Rhodes, S Rayner.   

Abstract

Rhodamine 123 (Rh123) is a fluorescent dye which locates in the mitochondria of cells. It is a substrate for P-glycoprotein (Pgp) and can, therefore, be used as a molecular probe in studies of the multidrug resistance (MDR) phenotype. However, not all MDR cells overexpress Pgp. In some, the MDR phenotype is associated with expression of an alternative transporter molecule, the multidrug resistance-associated protein (MRP). We have studied the accumulation and efflux of Rh123 in MDR cells having both Pgp-mediated and MRP-associated phenotypes. In the mouse tumour parental cell line, EMT6/P, Rh123 accumulates rapidly to reach plateau levels by 90 min. Confocal microscopy confirms a localisation to the mitochondria. In the MDR subline, EMT6/AR1.0, which overexpresses Pgp and which is 10-fold resistant to Rh123 cytotoxicity, accumulation is dramatically reduced. Efflux of Rh123 from both resistant and parental lines is rapid but can be inhibited by reduced temperature or by the presence of cyclosporin A (5 micrograms/ml). Efflux from the parental line is probably due to the presence of very low, but detectable, levels of Pgp but the existence of other mechanisms cannot be ruled out. In contrast, the human lung cancer parental cell line COR-L23/P, and its MRP-associated (but Pgp-negative) MDR subline, COR-L23/R (which is 23-fold resistant to Rh123 cytotoxicity), accumulate Rh123 at similar rates for the first 30 min. The curves then diverge so that, at 180 min, the resistant cells contain only 70% of the Rh123 of parental cells. Confocal microscopy demonstrates a similar distribution of fluorescence in resistant and parental cells. Essentially no efflux of Rh123 occurs from parental cells, whereas 70% of the content is lost from resistant cells over a period of 150 min. Such efflux may again be inhibited by reduced temperature but cyclosporin A (5 micrograms/ml) has little effect. These observations should be borne in mind when interpreting Rh123 efflux data in terms of MDR mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7999426     DOI: 10.1016/0959-8049(94)90187-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  25 in total

1.  Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers.

Authors:  E Liang; J Proudfoot; M Yazdanian
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  The hexapeptide immunofan inhibits the MRP-dependent multidrug resistance of tumor cells.

Authors:  Yu N Korystov; V V Lebedev; V V Shaposhnikova; N V Ermakova; L N Kublik; L M Chailakhyan
Journal:  Dokl Biol Sci       Date:  2004 Mar-Apr

3.  Increase in multidrug transport activity is associated with oocyte maturation in sea stars.

Authors:  Troy A Roepke; Amro M Hamdoun; Gary N Cherr
Journal:  Dev Growth Differ       Date:  2006-12       Impact factor: 2.053

4.  Effect of five novel 5-substituted tetrandrine derivatives on P-glycoprotein-mediated inhibition and transport in Caco-2 cells.

Authors:  Zhonglian Cao; Dan Li; Li Liu; Ping Yang
Journal:  Oncol Lett       Date:  2018-09-24       Impact factor: 2.967

Review 5.  Diagnostics of multidrug resistance in cancer.

Authors:  G Szakács; K Jakab; F Antal; B Sarkadi
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

6.  Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer.

Authors:  Nusrat Chowdhury; Imran Vhora; Ketan Patel; Ravi Doddapaneni; Arindam Mondal; Mandip Singh
Journal:  Pharm Res       Date:  2017-09-05       Impact factor: 4.200

7.  Delivery of MDR1 small interfering RNA by self-complementary recombinant adeno-associated virus vector.

Authors:  Dong Xu; Doug McCarty; Alda Fernandes; Michael Fisher; R J Samulski; R L Juliano
Journal:  Mol Ther       Date:  2005-04       Impact factor: 11.454

8.  Radioligand-binding assay employing P-glycoprotein-overexpressing cells: testing drug affinities to the secretory intestinal multidrug transporter.

Authors:  S Döppenschmitt; H Spahn-Langguth; C G Regårdh; P Langguth
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

9.  Kinetic analysis of rhodamines efflux mediated by the multidrug resistance protein (MRP1).

Authors:  Chantarawan Saengkhae; Chatchanok Loetchutinat; Arlette Garnier-Suillerot
Journal:  Biophys J       Date:  2003-09       Impact factor: 4.033

10.  Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination.

Authors:  David M Truong; Gregory Kaler; Akash Khandelwal; Peter W Swaan; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2008-01-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.